Download PDF
CC BY-NC-ND 4.0 · Endosc Int Open 2022; 10(09): E1268-E1274
DOI: 10.1055/a-1871-8552
Original article

Screening for head and neck tumors in patients with esophageal squamous cell carcinoma and vice versa: a nationwide survey among medical specialists

Laurelle van Tilburg
1   Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Sophie A. van den Ban
1   Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Steffi E.M. van de Ven
1   Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Aniel Sewnaik
2   Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Marco J. Bruno
1   Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Manon C.W. Spaander
1   Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Robert J. Baatenburg de Jong
2   Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
,
Arjun D. Koch
1   Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background and study aims Retrospectively, minimally 5% of patients with esophageal squamous cell carcinoma (ESCC) and 11 % with head and neck squamous cell carcinoma (HNSCC) in Western countries developed a second primary tumor (SPT). SPT screening in ESCC and HNSCC patients is not implemented routinely in daily practice in many Western countries. This study aimed to assess medical specialist knowledge and opinions regarding screening for head and neck SPTs (HNSPTs) in ESCC patients and vice versa in the Netherlands.

Methods A nationwide survey among gastroenterologists and head and neck (HN) surgeons was conducted between December 2020 and March 2021. The survey consisted of 27 questions and focused on knowledge of medical specialists of the prevalence and opinions toward implementing screening for HNSPTs in ESCC patients and vice versa.

Results One hundred twenty-eight gastroenterologists (20.5 %) and 31 HN surgeons (50.0 %) completed the survey. The expected median prevalence of HNSPTs in ESCC was 7.0 % (interquartile range [IQR]: 5.0–15.0) among gastroenterologists and 5.0 % (IQR:3.0–8.0) among HN surgeons. For ESPTs in HNSCC, the expected median prevalence was 9.5 % (IQR: 5.0–12.0) among gastroenterologists and 4.0 % (IQR: 2.0–5.0) among HN surgeons. Screening for HNSPTs and ESPTs was considered promising by 35.2 % and 39.6 %, respectively, which increased to 54.7 % of the specialists after providing incidence data on SPTs. Of the HN surgeons, 41.3 % felt they were as capable as gastroenterologists of performing esophageal screening.

Conclusions This Dutch nationwide survey revealed a lack of knowledge and different perspectives among specialists about screening to detect SPTs in ESCC and HNSCC patients. Adequate education seems essential to increase awareness among specialists and improve SPT detection, independent of the need for implementation of screening for SPTs in ESCC and HNSCC patients.

Supplementary material



Publication History

Received: 04 February 2022

Accepted after revision: 30 May 2022

Article published online:
14 September 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Bugter O, van de Ven SEM, Hardillo JA. et al. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck 2019; 41: 1122-1130
    CrossrefPubMedGoogle Scholar
  • 2 Bugter O, van Iwaarden DLP, Dronkers EAC. et al. Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable. Head Nec 2019; 41: 1648-1655
    CrossrefPubMedGoogle Scholar
  • 3 van de Ven S, Bugter O, Hardillo JA. et al. Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis. United European Gastroenterol J 2019; 7: 1304-1311
    CrossrefPubMedGoogle Scholar
  • 4 van de Ven SE, Falger JM, Verhoeven RH. et al. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: A nationwide study in a Western population. United European Gastroenterol J 2020; DOI: 10.1177/2050640620977129.
    CrossrefPubMedGoogle Scholar
  • 5 Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968
    CrossrefPubMedGoogle Scholar
  • 6 Bugter O, Spaander MCW, Bruno MJ. et al. Optical detection of field cancerization in the buccal mucosa of patients with esophageal cancer. Clin Transl Gastroenterol 2018; 9: 152
    CrossrefPubMedGoogle Scholar
  • 7 Watanabe A, Hosokawa M, Taniguchi M. et al. Head and neck cancer associated with esophageal cancer. Auris Nasus Larynx 2007; 34: 207-211
    CrossrefPubMedGoogle Scholar
  • 8 Onochi K, Shiga H, Takahashi S. et al. Risk factors linking esophageal squamous cell carcinoma with head and neck cancer or gastric cancer. J Clin Gastroenterol 2019; 53: e164-e170
    CrossrefPubMedGoogle Scholar
  • 9 Lo OS, Law S, Wei WI. et al. Esophageal cancers with synchronous or antecedent head and neck cancers: a more formidable challenge?. Ann Surg Oncol 2008; 15: 1750-1756
    CrossrefPubMedGoogle Scholar
  • 10 Gong EJ, Kim DH, Ahn JY. et al. Routine endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma: a prospective study. Dis Esophagus 2016; 29: 752-759
    CrossrefPubMedGoogle Scholar
  • 11 Wang CH, Lee YC, Wang CP. et al. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety. Dig Endosc 2014; 26: 24-31
    CrossrefPubMedGoogle Scholar
  • 12 Arnold M, Ferlay J, van Berge Henegouwen MI. et al. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 2020; 69: 1564-1571
    CrossrefPubMedGoogle Scholar
  • 13 Ferlay J, Colombet M, Soerjomataram I. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144: 1941-1953
    CrossrefPubMedGoogle Scholar
  • 14 Hashimoto CL, Iriya K, Baba ER. et al. Lugolʼs dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol 2005; 100: 275-282
    CrossrefPubMedGoogle Scholar
  • 15 Dubuc J, Legoux J, Winnock M. et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 2006; 38: 690-695
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Boller D, Spieler P, Schoenegg R. et al. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma. Surg Endosc 2009; 23: 2748-2754
    CrossrefPubMedGoogle Scholar
  • 17 van de Ven SEM, de Graaf W, Bugter O. et al. Screening for synchronous esophageal second primary tumors in patients with head and neck cancer. Dis Esophagus 2021; 34: doab037
    CrossrefPubMedGoogle Scholar
  • 18 Nobre Moura R, Kuboki Y, Baba ER. et al. Long-term results of an endoscopic screening program for superficial esophageal cancer in patients with head and neck squamous cell carcinoma. Endosc Int Open 2022; 10: E200-E208
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines 5th edition 2016. Available at: https://www.entuk.org/resources/131/5th_edition_head_and_neck_cancer_multidisciplinary_management_guidelines/
    PubMedGoogle Scholar
  • 20 Guideline esophageal cancer (in Dutch: Richtlijn Oesofaguscarcinoom): Dutch society of gastroenterologists; Version 3.1. Available at: https://www.mdl.nl/sites/www.mdl.nl/files/richlijnen/Richtlijn_Oesofaguscarcinoom.pdf
    PubMedGoogle Scholar
  • 21 Wang WL, Wang CP, Wang HP. et al. The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer. Oral Oncol 2013; 49: 808-813
    CrossrefPubMedGoogle Scholar
  • 22 Chung CS, Lo WC, Lee YC. et al. Image-enhanced endoscopy for detection of second primary neoplasm in patients with esophageal and head and neck cancer: A systematic review and meta-analysis. Head Neck 2016; 38: E2343-E2349
    CrossrefPubMedGoogle Scholar
  • 23 Kumai Y, Shono T, Waki K. et al. Detection of hypopharyngeal cancer (Tis, T1 and T2) by ENT physicians vs gastrointestinal endoscopists. Auris Nasus Larynx 2020; 47: 135-140
    CrossrefPubMedGoogle Scholar
  • 24 Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. I. Introduction and presentation of data. . Cancer 1961; 14: 221-230
    CrossrefPubMedGoogle Scholar
  • 25 Leemans CR, Smeele LE, Langendijk JA. et al. Guideline head and neck cancer (in Dutch: richtlijn Hoofd-halstumoren) 2012. Available at: https://richtlijnendatabase.nl/richtlijn/hoofd-halstumoren/hoofd-halstumoren_-_korte_beschrijving.html
    PubMedGoogle Scholar
  • 26 de Mones E, Bertolus C, Salaun PY. et al. Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 2013; 130: 107-112
    CrossrefPubMedGoogle Scholar
  • 27 Su H-A, Hsiao S-W, Hsu Y-C. et al. Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis. BMC Cancer 2020; 20: 1-9
    CrossrefPubMedGoogle Scholar
  • 28 Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngology Head Neck Surgery 2019; 48: 1-5
    CrossrefPubMedGoogle Scholar
  • 29 Van Kooten H, de Jonge V, Schreuders E. et al. Awareness of postpolypectomy surveillance guidelines: a nationwide survey of colonoscopists in Canada. Canadian J Gastroenterol 2012; 26: 79-84
    CrossrefPubMedGoogle Scholar